Low-GDP fluid (Gambrosol trio®) attenuates decline of residual renal function in PD patients: a prospective randomized study
Haag-Weber M, Krämer R, Haake R, Islam MS, Prischl F, Haug U, Nabut JL, Deppisch R, behalf of the DIUREST Study Group. Nephrol Dial Transplant. 2010 Jul;25(7):2288-96
This randomized controlled trial of low GDP vs standard peritoneal dialysis solutions concluded that low GDP solutions successfully preserved residual renal function.
See the accompanying editorial by Dr. Joanne Bargman for a critical analysis of the paper.
Related Articles:
- Slouching towards Bethlehem: the beast of biocompatibility
- Preserving residual renal function in peritoneal dialysis: volume or biocompatibility?
- Therapeutic Interventions for Systemic Vasculitis
Recent Comments